Procter & Gamble (PG)
(Delayed Data from NYSE)
$169.93 USD
+0.82 (0.48%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $170.28 +0.35 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$169.93 USD
+0.82 (0.48%)
Updated Jul 29, 2024 04:00 PM ET
After-Market: $170.28 +0.35 (0.21%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Zacks News
Is P&G (PG) a Buy as Wall Street Analysts Look Optimistic?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Why the Market Dipped But Procter & Gamble (PG) Gained Today
by Zacks Equity Research
Procter & Gamble (PG) closed at $159.56 in the latest trading session, marking a +0.45% move from the prior day.
The Zacks Analyst Blog Highlights Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic
by Zacks Equity Research
Eli Lilly, The Procter & Gamble, Morgan Stanley, AT&T and Medtronic are part of the Zacks top Analyst Blog.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Top Analyst Reports for Eli Lilly, Procter & Gamble & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Eli Lilly and Company (LLY), The Procter & Gamble Company (PG) and Morgan Stanley (MS).
Procter & Gamble (PG) Sees a More Significant Dip Than Broader Market: Some Facts to Know
by Zacks Equity Research
The latest trading day saw Procter & Gamble (PG) settling at $160.22, representing a -0.5% change from its previous close.
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
3 Companies Enjoying Meaningful Margin Expansion
by Derek Lewis
A favorable operating environment has led to increased profitability for many companies, causing many to see shares jump post-earnings throughout the 2023 Q4 cycle so far.
Company News for Jan 24, 2024
by Zacks Equity Research
Companies in The News Are: CBRE, VZ, PG, PEP
3 Hot Stocks to Buy Following Guidance Lifts
by Derek Lewis
Guidance lifts are among the most positive announcements shareholders can hear, injecting confidence in the long-term picture. Unsurprisingly, all three of these stocks popped following the lifts.
Mixed Q4 Earnings Report
by Zacks Equity Research
Mixed Q4 Earnings Report
Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results reflect robust pricing, along with growth across all segments. All its business segments have seen growth in organic sales.
Q4 Earnings for J&J, Procter, GE & More
by Mark Vickery
Pre-market trading fortunes are mixed for this morning's reportees, including JNJ, PG, GE, MMM and DHI.
Are You a Momentum Investor? This 1 Stock Could Be the Perfect Pick
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
P&G (PG) Q2 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for P&G (PG) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Procter & Gamble (PG) Q2 Earnings Top Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of 8.24% and 0.49%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Bulls Dominate as Economic Goldilocks Scenario Pushes Equities Into the Nosebleed Section
by Mayur Thaker
...however, underlying leading economic indicators continue to diverge from equity p/e multiples.
The Zacks Analyst Blog Highlights Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific
by Zacks Equity Research
Microsoft, Procter & Gamble, AstraZeneca, General Electric and Boston Scientific are included in this Analyst Blog.
Top Research Reports for Microsoft, Procter & Gamble & AstraZeneca
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), The Procter & Gamble Company (PG) and AstraZeneca PLC (AZN).
Solid Brand Portfolio to Aid Procter & Gamble's (PG) Q2 Earnings
by Zacks Equity Research
Procter & Gamble's (PG) Q2 results are expected to reflect the benefits of a robust brand portfolio, cost-saving and productivity measures, and effective business strategies, offset by elevated costs.
Colgate-Palmolive (CL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Colgate-Palmolive (CL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
4 Stocks Set to Grow in the Thriving Soap & Cleaning Materials Industry
by Rajani Lohia
The soap and cleaning materials industry looks poised for growth on favorable demand trends, pricing efforts, innovation, digital transformation and brand building amid elevated costs. Players like PG, CL, CHD and CLX look well-poised.
Should You Invest in the iShares U.S. Consumer Staples ETF (IYK)?
by Zacks Equity Research
Sector ETF report for IYK
Zacks Investment Ideas feature highlights: Microsoft, Procter & Gamble and United Rentals
by Zacks Equity Research
Microsoft, Procter & Gamble and United Rentals have been highlighted in this Investment Ideas article.
Countdown to P&G (PG) Q2 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for P&G (PG), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.